Researchers have found that ZnT-1 in the hippocampus/parahippocampal gyrus (HPG) in preclinical AD patients was significantly decreased [115], and the same was true in mild cognitive impairment (MCI) patients [105]. This evidence concerns the gene SLC30A1 and Alzheimer disease.